Global Pediatric Epilepsy Therapeutics Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1599

Epilepsy is one of the most common and challenging neurologic disorders affecting children.
Pediatric epilepsies present particular challenges, including correct diagnoses, comorbidities and interactions with developmental processes in the brain.
In 2018, the global Pediatric Epilepsy Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Pediatric Epilepsy Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pediatric Epilepsy Therapeutics development in United States, Europe and China.

The key players covered in this study
Abbott Laboratories
GlaxoSmithKline
Cephalon
Pfizer
Novartis
Sunovion Pharmaceuticals
Valeant Pharmaceuticals
Sanofi

Market segment by Type, the product can be split into
Benign Rolandic Epilepsy
Childhood Absence Epilepsy
Juvenile Myoclonic Epilepsy
Infantile Spasms
Lennox-Gastaut Syndrome

Market segment by Application, split into
Hospitals
Neurology Centers
Home Care Settings
Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Pediatric Epilepsy Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Pediatric Epilepsy Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Pediatric Epilepsy Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Pediatric Epilepsy Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Benign Rolandic Epilepsy
1.4.3 Childhood Absence Epilepsy
1.4.4 Juvenile Myoclonic Epilepsy
1.4.5 Infantile Spasms
1.4.6 Lennox-Gastaut Syndrome
1.5 Market by Application
1.5.1 Global Pediatric Epilepsy Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Neurology Centers
1.5.4 Home Care Settings
1.5.5 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Pediatric Epilepsy Therapeutics Market Size
2.2 Pediatric Epilepsy Therapeutics Growth Trends by Regions
2.2.1 Pediatric Epilepsy Therapeutics Market Size by Regions (2014-2025)
2.2.2 Pediatric Epilepsy Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Pediatric Epilepsy Therapeutics Market Size by Manufacturers
3.1.1 Global Pediatric Epilepsy Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Pediatric Epilepsy Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Pediatric Epilepsy Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Pediatric Epilepsy Therapeutics Key Players Head office and Area Served
3.3 Key Players Pediatric Epilepsy Therapeutics Product/Solution/Service
3.4 Date of Enter into Pediatric Epilepsy Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Pediatric Epilepsy Therapeutics Market Size by Type (2014-2019)
4.2 Global Pediatric Epilepsy Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Pediatric Epilepsy Therapeutics Market Size (2014-2019)
5.2 Pediatric Epilepsy Therapeutics Key Players in United States
5.3 United States Pediatric Epilepsy Therapeutics Market Size by Type
5.4 United States Pediatric Epilepsy Therapeutics Market Size by Application

6 Europe
6.1 Europe Pediatric Epilepsy Therapeutics Market Size (2014-2019)
6.2 Pediatric Epilepsy Therapeutics Key Players in Europe
6.3 Europe Pediatric Epilepsy Therapeutics Market Size by Type
6.4 Europe Pediatric Epilepsy Therapeutics Market Size by Application

7 China
7.1 China Pediatric Epilepsy Therapeutics Market Size (2014-2019)
7.2 Pediatric Epilepsy Therapeutics Key Players in China
7.3 China Pediatric Epilepsy Therapeutics Market Size by Type
7.4 China Pediatric Epilepsy Therapeutics Market Size by Application

8 Japan
8.1 Japan Pediatric Epilepsy Therapeutics Market Size (2014-2019)
8.2 Pediatric Epilepsy Therapeutics Key Players in Japan
8.3 Japan Pediatric Epilepsy Therapeutics Market Size by Type
8.4 Japan Pediatric Epilepsy Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Pediatric Epilepsy Therapeutics Market Size (2014-2019)
9.2 Pediatric Epilepsy Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Pediatric Epilepsy Therapeutics Market Size by Type
9.4 Southeast Asia Pediatric Epilepsy Therapeutics Market Size by Application

10 India
10.1 India Pediatric Epilepsy Therapeutics Market Size (2014-2019)
10.2 Pediatric Epilepsy Therapeutics Key Players in India
10.3 India Pediatric Epilepsy Therapeutics Market Size by Type
10.4 India Pediatric Epilepsy Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Pediatric Epilepsy Therapeutics Market Size (2014-2019)
11.2 Pediatric Epilepsy Therapeutics Key Players in Central & South America
11.3 Central & South America Pediatric Epilepsy Therapeutics Market Size by Type
11.4 Central & South America Pediatric Epilepsy Therapeutics Market Size by Application

12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Pediatric Epilepsy Therapeutics Introduction
12.1.4 Abbott Laboratories Revenue in Pediatric Epilepsy Therapeutics Business (2014-2019)
12.1.5 Abbott Laboratories Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Company Details
12.2.2 Company Description and Business Overview
12.2.3 Pediatric Epilepsy Therapeutics Introduction
12.2.4 GlaxoSmithKline Revenue in Pediatric Epilepsy Therapeutics Business (2014-2019)
12.2.5 GlaxoSmithKline Recent Development
12.3 Cephalon
12.3.1 Cephalon Company Details
12.3.2 Company Description and Business Overview
12.3.3 Pediatric Epilepsy Therapeutics Introduction
12.3.4 Cephalon Revenue in Pediatric Epilepsy Therapeutics Business (2014-2019)
12.3.5 Cephalon Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Pediatric Epilepsy Therapeutics Introduction
12.4.4 Pfizer Revenue in Pediatric Epilepsy Therapeutics Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Pediatric Epilepsy Therapeutics Introduction
12.5.4 Novartis Revenue in Pediatric Epilepsy Therapeutics Business (2014-2019)
12.5.5 Novartis Recent Development
12.6 Sunovion Pharmaceuticals
12.6.1 Sunovion Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Pediatric Epilepsy Therapeutics Introduction
12.6.4 Sunovion Pharmaceuticals Revenue in Pediatric Epilepsy Therapeutics Business (2014-2019)
12.6.5 Sunovion Pharmaceuticals Recent Development
12.7 Valeant Pharmaceuticals
12.7.1 Valeant Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Pediatric Epilepsy Therapeutics Introduction
12.7.4 Valeant Pharmaceuticals Revenue in Pediatric Epilepsy Therapeutics Business (2014-2019)
12.7.5 Valeant Pharmaceuticals Recent Development
12.8 Sanofi
12.8.1 Sanofi Company Details
12.8.2 Company Description and Business Overview
12.8.3 Pediatric Epilepsy Therapeutics Introduction
12.8.4 Sanofi Revenue in Pediatric Epilepsy Therapeutics Business (2014-2019)
12.8.5 Sanofi Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details